These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
505 related items for PubMed ID: 10102457
1. Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different? Turkstra F, Karemaker R, Kuijer PM, Prins MH, Büller HR. Thromb Haemost; 1999 Mar; 81(3):345-8. PubMed ID: 10102457 [Abstract] [Full Text] [Related]
2. Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutation. Manten B, Westendorp RG, Koster T, Reitsma PH, Rosendaal FR. Thromb Haemost; 1996 Oct; 76(4):510-3. PubMed ID: 8902987 [Abstract] [Full Text] [Related]
3. Low prevalence of factor V:Q506 in 41 patients with isolated pulmonary embolism. Martinelli I, Cattaneo M, Panzeri D, Mannucci PM. Thromb Haemost; 1997 Mar; 77(3):440-3. PubMed ID: 9065990 [Abstract] [Full Text] [Related]
4. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism. Emmerich J, Rosendaal FR, Cattaneo M, Margaglione M, De Stefano V, Cumming T, Arruda V, Hillarp A, Reny JL. Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312 [Abstract] [Full Text] [Related]
5. Prevalence of factor V Leiden and prothrombin 20210 A variant in Bulgarian patients with pulmonary thromboembolism and deep venous thrombosis. Boyanovsky B, Russeva M, Ganev V, Penev M, Baleva M. Blood Coagul Fibrinolysis; 2001 Dec; 12(8):639-42. PubMed ID: 11734663 [Abstract] [Full Text] [Related]
6. Factor V Leiden is associated with higher risk of deep venous thrombosis of large blood vessels. Arsov T, Miladinova D, Spiroski M. Croat Med J; 2006 Jun; 47(3):433-9. PubMed ID: 16758522 [Abstract] [Full Text] [Related]
7. Factors V leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis. Meyer G, Emmerich J, Helley D, Arnaud E, Nicaud V, Alhenc-Gelas M, Aiach M, Fischer A, Sors H, Fiessinger JN. Am J Med; 2001 Jan; 110(1):12-5. PubMed ID: 11152859 [Abstract] [Full Text] [Related]
8. The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden). Simioni P, Prandoni P, Lensing AW, Scudeller A, Sardella C, Prins MH, Villalta S, Dazzi F, Girolami A. N Engl J Med; 1997 Feb 06; 336(6):399-403. PubMed ID: 9010145 [Abstract] [Full Text] [Related]
9. Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation. Ridker PM, Glynn RJ, Miletich JP, Goldhaber SZ, Stampfer MJ, Hennekens CH. Ann Intern Med; 1997 Apr 01; 126(7):528-31. PubMed ID: 9092318 [Abstract] [Full Text] [Related]
10. Relative risk of pulmonary embolism and deep vein thrombosis in association with the factor V Leiden mutation in a United Kingdom population. Baglin TP, Brown K, Williamson D, Baker P, Luddington R. Thromb Haemost; 1997 Jun 01; 77(6):1219. PubMed ID: 9241762 [No Abstract] [Full Text] [Related]
11. Factor V Leiden and fatal pulmonary embolism. Vandenbroucke JP, Bertina RM, Holmes ZR, Spaargaren C, van Krieken JH, Manten B, Reitsma PH. Thromb Haemost; 1998 Mar 01; 79(3):511-6. PubMed ID: 9531031 [Abstract] [Full Text] [Related]
12. Testing for factor V Leiden in patients with pulmonary or venous thromboembolism: a cost-effectiveness analysis. Eckman MH, Singh SK, Erban JK, Kao G. Med Decis Making; 2002 Mar 01; 22(2):108-24. PubMed ID: 11958494 [Abstract] [Full Text] [Related]
13. Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism. de Moerloose P, Reber G, Perrier A, Perneger T, Bounameaux H. Br J Haematol; 2000 Jul 01; 110(1):125-9. PubMed ID: 10930988 [Abstract] [Full Text] [Related]
14. Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden. Hirsch DR, Mikkola KM, Marks PW, Fox EA, Dorfman DM, Ewenstein BM, Goldhaber SZ. Am Heart J; 1996 Jun 01; 131(6):1145-8. PubMed ID: 8644593 [Abstract] [Full Text] [Related]
15. Combined genetic mutations have remarkable effect on deep venous thrombosis and/or pulmonary embolism occurence. Simsek E, Yesilyurt A, Pinarli F, Eyerci N, Ulus AT. Gene; 2014 Feb 15; 536(1):171-6. PubMed ID: 24334115 [Abstract] [Full Text] [Related]
16. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population]. Ehrenforth S, Klinke S, von Depka Prondzinski M, Kreuz W, Ganser A, Scharrer I. Dtsch Med Wochenschr; 1999 Jun 25; 124(25-26):783-7. PubMed ID: 10414227 [Abstract] [Full Text] [Related]
17. Factor V Leiden and the risk for venous thromboembolism in the adult Danish population. Juul K, Tybjaerg-Hansen A, Schnohr P, Nordestgaard BG. Ann Intern Med; 2004 Mar 02; 140(5):330-7. PubMed ID: 14996674 [Abstract] [Full Text] [Related]
18. Long-term, low-dose warfarin among venous thrombosis patients with and without factor V Leiden mutation: rationale and design for the Prevention of Recurrent Venous Thromboembolism (PREVENT) trial. Ridker PM. Vasc Med; 1998 Mar 02; 3(1):67-73. PubMed ID: 9666536 [Abstract] [Full Text] [Related]
19. Factor V Leiden: should we screen oral contraceptive users and pregnant women? Vandenbroucke JP, van der Meer FJ, Helmerhorst FM, Rosendaal FR. BMJ; 1996 Nov 02; 313(7065):1127-30. PubMed ID: 8916702 [Abstract] [Full Text] [Related]
20. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. N Engl J Med; 1995 Apr 06; 332(14):912-7. PubMed ID: 7877648 [Abstract] [Full Text] [Related] Page: [Next] [New Search]